Antibody Responses to Norovirus Genogroup GI.1 and GII.4 Proteases in Volunteers Administered Norwalk Virus
Open Access
- 1 December 2012
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 19 (12) , 1980-1983
Abstract
An assay was developed to detect antibodies against two norovirus proteases among participants in a Norwalk virus (GI.1) challenge study. Prechallenge seroprevalence was lower against the protease from the homologous GI.1 virus than against protease from a heterologous GII.4 strain. Seroresponses were detected for 14 of 19 (74%) infected persons.Keywords
This publication has 21 references indexed in Scilit:
- Norovirus Vaccine against Experimental Human Norwalk Virus IllnessNew England Journal of Medicine, 2011
- Serological Responses to Experimental Norwalk Virus Infection Measured Using a Quantitative Duplex Time-Resolved Fluorescence ImmunoassayClinical and Vaccine Immunology, 2011
- Serological Correlate of Protection against Norovirus‐Induced GastroenteritisThe Journal of Infectious Diseases, 2010
- Rapid Evolution of Pandemic Noroviruses of the GII.4 LineagePLOS Pathogens, 2010
- Heterotypic Humoral and Cellular Immune Responses following Norwalk Virus InfectionJournal of Virology, 2010
- Norwalk Virus Shedding after Experimental Human InfectionEmerging Infectious Diseases, 2008
- X-Ray Crystallographic Structure of the Norwalk Virus Protease at 1.5-Å ResolutionJournal of Virology, 2006
- Immunoassay Targeting Nonstructural Protein 5 To Differentiate West Nile Virus Infection from Dengue and St. Louis Encephalitis Virus Infections and from Flavivirus VaccinationJournal of Clinical Microbiology, 2003
- Foot-and-mouth disease virus-infected but not vaccinated cattle develop antibodies against recombinant 3AB1 nonstructural proteinArchives of Virology, 1997
- Host Antibody Response to Viral Structural and Nonstructural Proteins after Hepatitis A Virus InfectionThe Journal of Infectious Diseases, 1992